Stay updated on FLYSYN-101 Clinical Trial in MRD Positive AML
Sign up to get notified when there's something new on the FLYSYN-101 Clinical Trial in MRD Positive AML page.

Latest updates to the FLYSYN-101 Clinical Trial in MRD Positive AML page
- CheckyesterdayChange DetectedPage revision updated from v3.0.1 to v3.0.2. The 'Back to Top' element was removed.SummaryDifference0.2%
- Check9 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, names, pricing, or availability.SummaryDifference0.2%
- Check16 days agoChange DetectedThe web page has updated its facility name and location details, adding specific locations in Baden-Wurttemberg and Lower Saxony, while removing previous location references. Additionally, it has revised its content related to genetic diseases, focusing on acute myeloid leukemia.SummaryDifference3%
- Check23 days agoChange DetectedThere are no significant changes to the web page content.SummaryDifference0.8%
- Check30 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12, indicating a revision in the content.SummaryDifference0.8%
- Check37 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
Stay in the know with updates to FLYSYN-101 Clinical Trial in MRD Positive AML
Enter your email address, and we'll notify you when there's something new on the FLYSYN-101 Clinical Trial in MRD Positive AML page.